Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jul 15;98(2):308–316. doi: 10.1172/JCI118794

Interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system in follicular growth and ovulation.

Y Yoshimura 1, N Aoki 1, K Sueoka 1, T Miyazaki 1, N Kuji 1, M Tanaka 1, T Kobayashi 1
PMCID: PMC507432  PMID: 8755639

Abstract

The interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system (RAS) in follicular growth and ovulation were studied with the use of an isolated perfused rabbit ovary preparation. Ovulation failed to occur in either control ovaries or the experimental ovaries perfused with IGF-I in a concentration of 1, 10, or 100 ng/ml in the absence of gonadotropin. Exposure to IGF-I stimulated the secretion rate of angiotensin II-like immunoreactivity (Ang II-IR) in perfused rabbit ovaries in a dose-dependent manner. The percent increase in follicle diameter in ovaries perfused with IGF-I for 12 h was significantly correlated with the secretion rate of Ang II-IR at 12 h after exposure to IGF-I. The addition of IGFBP-3 to the perfusate did not induce ovulation in the absence of gonadotropin, but exposure to IGFBP-3 inhibited hCG-induced ovulation in a dose-dependent manner. In addition, IGFBP-3 significantly reduced the ovarian secretion rate of Ang II-IR and prostaglandins stimulated by hCG administration. Intrafollicular plasminogen activator (PA) activity significantly increased within 4 h after exposure to 100 ng/ml of IGF-I, compared with that in control ovaries perfused with medium alone. The concomitant addition of IGFBP-3 to the perfusate significantly reduced the IGF-I-stimulated PA activity in the preovulatory follicles at 4, 6, and 8 h after exposure to IGF-I. However, IGFBP-3 alone affected neither the ovarian secretion rate of Ang II-IR nor intrafollicular PA activity. Exposure to streptokinase, an exogenous PA, in vitro stimulated both follicular growth and the intrafollicular Ang II-IR content. In conclusion, IGF-I enhances both ovarian Ang II production and follicular development by stimulating intrafollicular PA activity.

Full Text

The Full Text of this article is available as a PDF (208.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adashi E. Y., Resnick C. E., D'Ercole A. J., Svoboda M. E., Van Wyk J. J. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev. 1985 Summer;6(3):400–420. doi: 10.1210/edrv-6-3-400. [DOI] [PubMed] [Google Scholar]
  2. Adashi E. Y., Resnick C. E., Hurwitz A., Ricciarelli E., Hernandez E. R., Rosenfeld R. G. Ovarian granulosa cell-derived insulin-like growth factor binding proteins: modulatory role of follicle-stimulating hormone. Endocrinology. 1991 Feb;128(2):754–760. doi: 10.1210/endo-128-2-754. [DOI] [PubMed] [Google Scholar]
  3. Beardwell C. G. Radioimmunoassay of arginine vasopressin in human plasma. J Clin Endocrinol Metab. 1971 Aug;33(2):254–260. doi: 10.1210/jcem-33-2-254. [DOI] [PubMed] [Google Scholar]
  4. Bicsak T. A., Ling N., DePaolo L. V. Ovarian intrabursal administration of insulin-like growth factor-binding protein inhibits follicle rupture in gonadotropin-treated immature female rats. Biol Reprod. 1991 Apr;44(4):599–603. doi: 10.1095/biolreprod44.4.599. [DOI] [PubMed] [Google Scholar]
  5. Bicsak T. A., Ling N., DePaolo L. V. Ovarian intrabursal administration of insulin-like growth factor-binding protein inhibits follicle rupture in gonadotropin-treated immature female rats. Biol Reprod. 1991 Apr;44(4):599–603. doi: 10.1095/biolreprod44.4.599. [DOI] [PubMed] [Google Scholar]
  6. Bicsak T. A., Shimonaka M., Malkowski M., Ling N. Insulin-like growth factor-binding protein (IGF-BP) inhibition of granulosa cell function: effect on cyclic adenosine 3',5'-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody. Endocrinology. 1990 Apr;126(4):2184–2189. doi: 10.1210/endo-126-4-2184. [DOI] [PubMed] [Google Scholar]
  7. Burch W. M., Correa J., Shively J. E., Powell D. R. The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro. J Clin Endocrinol Metab. 1990 Jan;70(1):173–180. doi: 10.1210/jcem-70-1-173. [DOI] [PubMed] [Google Scholar]
  8. Canipari R., Strickland S. Plasminogen activator in the rat ovary. Production and gonadotropin regulation of the enzyme in granulosa and thecal cells. J Biol Chem. 1985 Apr 25;260(8):5121–5125. [PubMed] [Google Scholar]
  9. Culler M. D., Tarlatzis B. C., Lightman A., Fernandez L. A., Decherney A. H., Negro-Vilar A., Naftolin F. Angiotensin II-like immunoreactivity in human ovarian follicular fluid. J Clin Endocrinol Metab. 1986 Mar;62(3):613–615. doi: 10.1210/jcem-62-3-613. [DOI] [PubMed] [Google Scholar]
  10. Davoren J. B., Hsueh J. W., Li C. H. Somatomedin C augments FSH-induced differentiation of cultured rat granulosa cells. Am J Physiol. 1985 Jul;249(1 Pt 1):E26–E33. doi: 10.1152/ajpendo.1985.249.1.E26. [DOI] [PubMed] [Google Scholar]
  11. Davoren J. B., Kasson B. G., Li C. H., Hsueh A. J. Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: relation to IGF action. Endocrinology. 1986 Nov;119(5):2155–2162. doi: 10.1210/endo-119-5-2155. [DOI] [PubMed] [Google Scholar]
  12. De Vroede M. A., Tseng L. Y., Katsoyannis P. G., Nissley S. P., Rechler M. M. Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media. J Clin Invest. 1986 Feb;77(2):602–613. doi: 10.1172/JCI112343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dzau V. J., Brenner A., Emmett N. L. Evidence for renin in rat brain: differentiation from other reninlike enzymes. Am J Physiol. 1982 May;242(5):E292–E297. doi: 10.1152/ajpendo.1982.242.5.E292. [DOI] [PubMed] [Google Scholar]
  14. Dzau V. J., Gonzalez D., Ellison K., Churchill S., Emmett N. Characterization of purified rabbit uterine renin: influence of pregnancy on uterine inactive renin. Endocrinology. 1987 Jan;120(1):358–364. doi: 10.1210/endo-120-1-358. [DOI] [PubMed] [Google Scholar]
  15. Dzau V. J. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol. 1984;6 (Suppl 2):S377–S382. [PubMed] [Google Scholar]
  16. Elgin R. G., Busby W. H., Jr, Clemmons D. R. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci U S A. 1987 May;84(10):3254–3258. doi: 10.1073/pnas.84.10.3254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Erickson G. F., Garzo V. G., Magoffin D. A. Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. J Clin Endocrinol Metab. 1989 Oct;69(4):716–724. doi: 10.1210/jcem-69-4-716. [DOI] [PubMed] [Google Scholar]
  18. Fattal P. G., Schneider D. J., Sobel B. E., Billadello J. J. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J Biol Chem. 1992 Jun 25;267(18):12412–12415. [PubMed] [Google Scholar]
  19. Glorioso N., Atlas S. A., Laragh J. H., Jewelewicz R., Sealey J. E. Prorenin in high concentrations in human ovarian follicular fluid. Science. 1986 Sep 26;233(4771):1422–1424. doi: 10.1126/science.3529392. [DOI] [PubMed] [Google Scholar]
  20. Husain A., Smeby R. R., Wilk D., Dzau V. J., Bumpus F. M. Biochemical and immunological properties of dog brain isorenin. Endocrinology. 1984 Jun;114(6):2210–2215. doi: 10.1210/endo-114-6-2210. [DOI] [PubMed] [Google Scholar]
  21. Ichikawa F., Yoshimura Y., Oda T., Shiraki M., Maruyama K., Kawakami S., Nakamura Y., Fukushima M. The effects of lipoxygenase products on progesterone and prostaglandin production by human corpora lutea. J Clin Endocrinol Metab. 1990 Apr;70(4):849–855. doi: 10.1210/jcem-70-4-849. [DOI] [PubMed] [Google Scholar]
  22. Kim S., Shinjo M., Fukamizu A., Miyazaki H., Usuki S., Murakami K. Identification of renin and renin messenger RNA sequence in rat ovary and uterus. Biochem Biophys Res Commun. 1987 Jan 15;142(1):169–175. doi: 10.1016/0006-291x(87)90466-9. [DOI] [PubMed] [Google Scholar]
  23. Kobayashi Y., Wright K. H., Santulli R., Wallach E. E. Ovulation and ovum maturation in the rabbit ovary perfused in vitro. Biol Reprod. 1981 Apr;24(3):483–490. doi: 10.1095/biolreprod24.3.483. [DOI] [PubMed] [Google Scholar]
  24. Lightman A., Tarlatzis B. C., Rzasa P. J., Culler M. D., Caride V. J., Negro-Vilar A. F., Lennard D., DeCherney A. H., Naftolin F. The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid. Am J Obstet Gynecol. 1987 Apr;156(4):808–816. doi: 10.1016/0002-9378(87)90336-x. [DOI] [PubMed] [Google Scholar]
  25. Liu L., Brinkman A., Blat C., Harel L. IGFBP-1, an insulin like growth factor binding protein, is a cell growth inhibitor. Biochem Biophys Res Commun. 1991 Jan 31;174(2):673–679. doi: 10.1016/0006-291x(91)91470-w. [DOI] [PubMed] [Google Scholar]
  26. Mondschein J. S., Smith S. A., Hammond J. M. Production of insulin-like growth factor binding proteins (IGFBPs) by porcine granulosa cells: identification of IGFBP-2 and -3 and regulation by hormones and growth factors. Endocrinology. 1990 Nov;127(5):2298–2306. doi: 10.1210/endo-127-5-2298. [DOI] [PubMed] [Google Scholar]
  27. Morimoto T., Aoyama M., Gotoh E., Shionoiri H. [A method for radioimmunoassay of plasma angiotensin II using florisil]. Nihon Naibunpi Gakkai Zasshi. 1983 Mar 20;59(3):215–229. doi: 10.1507/endocrine1927.59.3_215. [DOI] [PubMed] [Google Scholar]
  28. Ohkubo H., Nakayama K., Tanaka T., Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem. 1986 Jan 5;261(1):319–323. [PubMed] [Google Scholar]
  29. Oliver J. E., Aitman T. J., Powell J. F., Wilson C. A., Clayton R. N. Insulin-like growth factor I gene expression in the rat ovary is confined to the granulosa cells of developing follicles. Endocrinology. 1989 Jun;124(6):2671–2679. doi: 10.1210/endo-124-6-2671. [DOI] [PubMed] [Google Scholar]
  30. Pellicer A., Lightman A., Ariza A., DeCherney A. H., Naftolin F., Littlefield B. A. Follicular development is impaired by inhibitors of serine proteases in the rat. Am J Obstet Gynecol. 1988 Mar;158(3 Pt 1):670–676. doi: 10.1016/0002-9378(88)90051-8. [DOI] [PubMed] [Google Scholar]
  31. Pellicer A., Palumbo A., DeCherney A. H., Naftolin F. Blockage of ovulation by an angiotensin antagonist. Science. 1988 Jun 17;240(4859):1660–1661. doi: 10.1126/science.3381087. [DOI] [PubMed] [Google Scholar]
  32. Pfeilschifter J., Krempien R., Naumann A., Gronwald R. G., Hoppe J., Ziegler R. Differential effects of platelet-derived growth factor isoforms on plasminogen activator activity in fetal rat osteoblasts due to isoform-specific receptor functions. Endocrinology. 1992 Apr;130(4):2059–2066. doi: 10.1210/endo.130.4.1312439. [DOI] [PubMed] [Google Scholar]
  33. Sealey J. E., Cholst I., Glorioso N., Troffa C., Weintraub I. D., James G., Laragh J. H. Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J Clin Endocrinol Metab. 1987 Jul;65(1):1–5. doi: 10.1210/jcem-65-1-1. [DOI] [PubMed] [Google Scholar]
  34. Stoppelli M. P., Verde P., Grimaldi G., Locatelli E. K., Blasi F. Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate. J Cell Biol. 1986 Apr;102(4):1235–1241. doi: 10.1083/jcb.102.4.1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tonetta S. A., diZerega G. S. Intragonadal regulation of follicular maturation. Endocr Rev. 1989 May;10(2):205–229. doi: 10.1210/edrv-10-2-205. [DOI] [PubMed] [Google Scholar]
  36. Tranque P., Naftolin F., Robbins R. Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor. Endocrinology. 1994 Jun;134(6):2606–2613. doi: 10.1210/endo.134.6.8194486. [DOI] [PubMed] [Google Scholar]
  37. Tsafriri A., Bicsak T. A., Cajander S. B., Ny T., Hsueh A. J. Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin. Endocrinology. 1989 Jan;124(1):415–421. doi: 10.1210/endo-124-1-415. [DOI] [PubMed] [Google Scholar]
  38. Ui M., Shimonaka M., Shimasaki S., Ling N. An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells. Endocrinology. 1989 Aug;125(2):912–916. doi: 10.1210/endo-125-2-912. [DOI] [PubMed] [Google Scholar]
  39. Yoshimura Y., Iwashita M., Karube M., Oda T., Akiba M., Shiokawa S., Ando M., Yoshinaga A., Nakamura Y. Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor-I. Endocrinology. 1994 Sep;135(3):887–894. doi: 10.1210/endo.135.3.8070383. [DOI] [PubMed] [Google Scholar]
  40. Yoshimura Y., Jinno M., Oda T., Shiokawa S., Yoshinaga A., Hanyu I., Akiba M., Nakamura Y. Prolactin inhibits ovulation by reducing ovarian plasmin generation. Biol Reprod. 1994 Jun;50(6):1223–1230. doi: 10.1095/biolreprod50.6.1223. [DOI] [PubMed] [Google Scholar]
  41. Yoshimura Y., Karube M., Koyama N., Shiokawa S., Nanno T., Nakamura Y. Angiotensin II directly induces follicle rupture and oocyte maturation in the rabbit. FEBS Lett. 1992 Aug 3;307(3):305–308. doi: 10.1016/0014-5793(92)80701-h. [DOI] [PubMed] [Google Scholar]
  42. Yoshimura Y., Karube M., Oda T., Koyama N., Shiokawa S., Akiba M., Yoshinaga A., Nakamura Y. Locally produced angiotensin II induces ovulation by stimulating prostaglandin production in in vitro perfused rabbit ovaries. Endocrinology. 1993 Oct;133(4):1609–1616. doi: 10.1210/endo.133.4.8404601. [DOI] [PubMed] [Google Scholar]
  43. Yoshimura Y., Koyama N., Karube M., Oda T., Akiba M., Yoshinaga A., Shiokawa S., Jinno M., Nakamura Y. Gonadotropin stimulates ovarian renin-angiotensin system in the rabbit. J Clin Invest. 1994 Jan;93(1):180–187. doi: 10.1172/JCI116943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yoshimura Y., Maruyama K., Shiraki M., Kawakami S., Fukushima M., Nakamura Y. Prolactin inhibits plasminogen activator activity in the preovulatory follicles. Endocrinology. 1990 Jan;126(1):631–636. doi: 10.1210/endo-126-1-631. [DOI] [PubMed] [Google Scholar]
  45. Yoshimura Y., Nagamatsu S., Ando M., Iwashita M., Oda T., Katsumata Y., Shiokawa S., Nakamura Y. Insulin-like growth factor binding protein-3 inhibits gonadotropin-induced ovulation, oocyte maturation, and steroidogenesis in rabbit ovary. Endocrinology. 1996 Feb;137(2):438–446. doi: 10.1210/endo.137.2.8593787. [DOI] [PubMed] [Google Scholar]
  46. Yoshimura Y., Nakamura Y., Oda T., Yamada H., Nanno T., Ando M., Ubukata Y., Suzuki M. Effects of gonadotropin-releasing hormone agonists on meiotic maturation of follicle-enclosed oocytes in rabbits. Biol Reprod. 1990 Dec;43(6):1012–1018. doi: 10.1095/biolreprod43.6.1012. [DOI] [PubMed] [Google Scholar]
  47. Yoshimura Y., Nakamura Y., Shiraki M., Hirota Y., Yamada H., Ando M., Ubukata Y., Suzuki M. Involvement of leukotriene B4 in ovulation in the rabbit. Endocrinology. 1991 Jul;129(1):193–199. doi: 10.1210/endo-129-1-193. [DOI] [PubMed] [Google Scholar]
  48. Yoshimura Y., Santulli R., Atlas S. J., Fujii S., Wallach E. E. The effects of proteolytic enzymes on in vitro ovulation in the rabbit. Am J Obstet Gynecol. 1987 Aug;157(2):468–475. doi: 10.1016/s0002-9378(87)80197-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES